Medicine
BEVACIZUMAB 400 EQUITY
Key ingredient(s)
0 Mg
Bevacizumab 400
Available forms & strengths
Request this medicine| Form | Strength | Pack | Route | Icon |
|---|---|---|---|---|
| CONCENTRATE FOR SOLUTION FOR INFUSION | 400,0 mg | — | Parenteral |
|
Notes: SAHPRA secureId: CfDJ8L67LitnFgdOq0Uv0zyh2bqJRrY40omLgDJZF9MeZqLmV4aeuFrzYKSB4lhm5WZmwGRpYCWyh4rr2mymHfwMV4XnTi63RbjSbVN4ODOJ1Q7UDwBm6WhDNh8vDw9A-fSVVQ | Reg: 56/26/0467 | AppNo: 560467 | RegDate: 2025/02/04 | Applicant: Equity Pharmaceutical (Pty) Ltd | Status: Registered